{
  "paper_metadata": {
    "pmid": "34079032",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR variant V122I, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.364G>A",
      "protein_notation": "p.Val122Ile",
      "genomic_position": "rs76992529",
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 243,
        "demographics": "Predominantly African ancestry, average age 59.6 years",
        "phenotype": "Common hATTR amyloidosis manifestations including polyneuropathy, cardiomyopathy, heart failure"
      },
      "penetrance_data": {
        "total_carriers_observed": 243,
        "affected_count": 2,
        "unaffected_count": 241,
        "uncertain_count": null,
        "penetrance_percentage": 0.82,
        "age_dependent_penetrance": [
          {
            "age_range": "75 years",
            "penetrance_percentage": 0.82,
            "carriers_in_range": 243,
            "affected_in_range": 2
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": 75,
          "age_at_onset": null,
          "age_at_diagnosis": 75,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Cardiac manifestations of disease",
          "evidence_sentence": "Both diagnosed patients were male heterozygous carriers, diagnosed at ages 75.9 and 71.9 years, and with cardiac manifestations of disease diagnosed during study follow-up."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": 71,
          "age_at_onset": null,
          "age_at_diagnosis": 71,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Cardiac manifestations of disease",
          "evidence_sentence": "Both diagnosed patients were male heterozygous carriers, diagnosed at ages 75.9 and 71.9 years, and with cardiac manifestations of disease diagnosed during study follow-up."
        }
      ],
      "functional_data": {
        "summary": "The V122I variant is associated with increased risk of hATTR amyloidosis manifestations.",
        "assays": []
      },
      "segregation_data": "The variant segregates with disease in the affected individuals.",
      "population_frequency": "2.0% in the African ancestry population",
      "evidence_level": "Strong evidence based on multiple studies and associations.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is significantly associated with polyneuropathy and other hATTR manifestations.",
      "key_quotes": [
        "V122I was significantly associated with polyneuropathy in the UK Biobank (odds ratio [OR]\u2009=\u20096.4, 95% confidence interval [CI] 2.6\u201315.6, p\u2009=\u20094.2\u2009\u00d7\u200910\u22125).",
        "By age 75, 37.4% of V122I carriers had at least one of these manifestations."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}